Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,071.2
6.7 (0.22%)

 

  • STI Straits Times Index
    3,071.2
    6.7 (0.22%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,548.5
    -6.8 (-0.43%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,920.8
    252.9 (1.03%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,614.0
    6.9 (0.19%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    30,500.0
    176.7 (0.58%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,133.2
    23.3 (0.38%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 2,452.5M
  • Value: 2,581.7M
  • Rise: 161
  • Fall: 177
  • Unch: 416

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Hatten Land0.073+0.013
ESR-REIT0.475-0.010
OUE Com Reit0.445-
Sembcorp Marine0.084+0.001
StarhillGbl Reit0.630-0.005
ARA LOGOS Log Tr0.935+0.010
GSS Energy0.077+0.005
Lippo Malls Tr0.054+0.003
Singtel2.430+0.030
CapLand IntCom T2.000-0.020

World Indices

World Indices
Name Last Change
Nasdaq 15,044.0 -138.0
HSI 24,920.8 +252.9
HSCEI 8,940.5 +134.7
Jakarta 6,133.2 +23.3
Nikkei 225 30,500.0 +176.7
SSE Comp 3,614.0 +6.9
Shanghai A 3,787.7 +7.3
Shanghai B 273.1 -1.8
KOSPI 3,140.5 +10.4

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

TOPGLOV TOP GLOVE CORPORATION BHD
Quotes 15 Minutes Delayed. Updated at 17 Sep 2021 16:59
Last (MYR): 3.060 Change: -0.140 High: 3.320 Remarks: s
Remarks legend:
RemarksDescriptionRemarksDescription
IOrder entry forbiddenAOrder entry authorized
GFrozenSSuspended
RReservedsShort selling available
[x]Exclude dividend[c] Cum dividend
Change (%): -4.38 Low: 2.950
Open 3.230 Yesterday's Close 3.200
Buy Price 3.050 Sell Price 3.060
Buy Volume ('00) 767 Sell Volume ('00) 998
Cumulative Volume ('00) 636,011 Cumulative Value 197,818,769
Click to show Stock Prices chart

Key Statistics

EPS (MYR) a 0.21894 Trailing EPS (MYR) e 1.07097 NAV (MYR) b 0.8591
PE a 13.976 Trailing PE f 2.857 Price / NAV b 3.5619
Dividend (MYR) d 0.120103 Cash In Hand (MYR) g 0.1265 Issued & Paid-up Shares c 8,004,830,434
Dividend Yield (%) d 3.925 Price / Cash In Hand g 24.190 Treasury Shares h 202,152,000
Beta - 75 Daysi 1.692 R-Squared - 75 Days(%)i 20.55 Market Cap (M) 24,494.781
Beta - 500 Daysi 1.318 R-Squared - 500 Days (%)i 13.35 Enterprise Value (M) 21,650.253
Piotroski F Score 8 Exchange Code 7113 Par Value ( MYR ) 0.50000
52 Weeks Volatility (%) 38.25 6-Month VWAP 4.565 Free Float (%) 56.3
Shariah Compliant Stocks Yes
Sector & Industry Health Technology - Medical Specialties
Index Components BM HEALTH CARE / FTSE Bursa Malaysia EMAS Index / FTSE Bursa Malaysia EMAS Shariah Index / FTSE Bursa Malaysia KLCI Index / FTSE Bursa Malaysia Top 100 Index
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 10 Sep 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 10 Sep 2021.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference TOPGLOV Bursa 24,494.781 13.976 2.857 3.5619 3.925
Industry HEALTH CARE EQUIPMENT & SERVICES Bursa 7,653.875 6.353 2.972 2.6940 5.173
Medical Specialties Bursa 8,962.916 6.367 3.107 2.9155 5.035
Index BM HEALTH CARE Bursa 7,702.835 12.876 5.845 2.6254 2.798
FTSE Bursa Malaysia EMAS Index Bursa 5,255.354 31.747 19.585 1.3037 2.625
FTSE Bursa Malaysia EMAS Shariah Index Bursa 4,566.944 30.666 16.418 1.5166 2.424
FTSE Bursa Malaysia KLCI Index Bursa 34,389.822 24.975 16.041 1.6663 2.682
FTSE Bursa Malaysia Top 100 Index Bursa 14,035.015 29.588 18.203 1.5537 2.451
Local Peer HARTA Bursa 21,871.757 7.580 4.441 3.3492 7.985
Local Peer SUPERMX Bursa 6,753.509 1.771 1.771 1.4205 -
Local Peer RGTBHD Bursa 275.712 27.538 27.533 2.6966 -
Local Peer ADVENTA Bursa 207.789 - - 3.3597 -
Local Peer LKL Bursa 173.950 - - 0.9058 -
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 234,792.459 36.830 27.314 6.3709 0.149
Global Peer DANAHER CORP NYSE 231,681.967 66.006 66.006 5.8671 0.221
Global Peer ABBOTT LABORATORIES NYSE 224,775.848 50.252 35.420 6.6502 1.206
Global Peer MEDTRONIC PLC NYSE 174,551.557 48.406 44.953 3.3903 1.865
Global Peer INTUITIVE SURGICAL INC NASDAQ 123,425.795 116.374 76.067 11.3888 -
Global Peer STRYKER CORP NYSE 102,958.521 64.389 49.428 7.4500 0.860
Global Peer BECTON DICKINSON & CO NYSE 75,229.420 98.083 40.337 3.1173 1.234
Global Peer EDWARDS LIFESCIENCES CORP NYSE 74,437.830 90.403 50.901 14.5010 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 63,176.224 - 134.992 3.9629 -
Global Peer ALIGN TECHNOLOGY INC NASDAQ 56,839.293 32.006 81.379 16.7944 -
Other Global Peers IDEXX LABORATORIES INC (NASDAQ), DEXCOM INC (NASDAQ), AGILENT TECHNOLOGIES INC (NYSE), KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 (NYSE), ALCON AG (NYSE), BAXTER INTERNATIONAL INC (NYSE), RESMED INC (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), WATERS CORP (NYSE), BIO RAD LABORATORIES INC (NYSE), COOPER COS INC (NYSE), STERIS PLC (NYSE), PERKINELMER INC (NYSE), INSULET CORPORATION (NASDAQ), HOLOGIC INC (NASDAQ), TELEFLEX INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), ABIOMED INC (NASDAQ), MASIMO CORPORATION (NASDAQ), NOVOCURE LTD (NASDAQ), DENTSPLY SIRONA INC (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), BRUKER CORPORATION (NASDAQ), QIAGEN NV (NYSE), COCHLEAR LTD (ASX), MICROPORT (HKEx), PENUMBRA INC (NYSE), HILL-ROM HOLDINGS INC (NYSE), GLOBUS MED INC (NYSE), SHOCKWAVE MEDICAL INC (NASDAQ), WEIGAO GROUP (HKEx), TANDEM DIABETES CARE INC (NASDAQ), SOTERA HEALTH CO (NASDAQ), ANGELALIGN (HKEx), ENVISTA HOLDINGS CORPORATION (NYSE), INSPIRE MEDICAL SYSTEMS INC (NYSE), STAAR SURGICAL CO (NASDAQ), QUIDEL CORP (NASDAQ), Top Glove (SGX), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), INMODE LTD (NASDAQ), ICU MEDICAL INC (NASDAQ), NEOGEN CORP (NASDAQ), NEVRO CORP (NYSE), LIVANOVA PLC (NASDAQ), EBOS GROUP (ASX), ORTHO CLINICAL DIAGNOSTICS HLD PLC (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), INARI MEDICAL INC (NASDAQ), CONMED CORP (NYSE), HAEMONETICS CORP (NYSE), CAREDX INC (NASDAQ), ATRICURE INC (NASDAQ), CYTEK BIOSCIENCES INC (NASDAQ), THE BEAUTY HEALTH COMPANY (NASDAQ), AXONICS INC (NASDAQ), NUVASIVE INC (NASDAQ), HESKA CORP (NASDAQ), OUTSET MEDICAL INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), GLAUKOS CORPORATION (NYSE), VENUS MEDTECH-B (HKEx), VERICEL CORP (NASDAQ), LIFETECH SCI (HKEx), BUTTERFLY NETWORK INC (NYSE), CARDIOFLOW-B (HKEx), SILK ROAD MEDICAL INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), PEIJIA-B (HKEx), ZYLOXTB-B (HKEx), LANTHEUS HOLDINGS INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), PROCEPT BIOROBOTICS CORP (NASDAQ), KANGJI MEDICAL (HKEx), MESA LABORATORIES INC (NASDAQ), AVANOS MEDICAL INC (NYSE), TREACE MED CONCEPTS INC (NASDAQ), AK MEDICAL (HKEx), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), PULMONX CORPORATION (NASDAQ), NANOSONICS LIMITED (ASX), ORTHOPEDIATRICS CORP (NASDAQ), ATRION CORP (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), SIGHT SCIENCES INC (NASDAQ), NANO-X IMAGING LTD (NASDAQ), CERUS CORP (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), INOGEN INC (NASDAQ), DERMTECH INC (NASDAQ), VIEWRAY INC (NASDAQ), 908 DEVICES INC (NASDAQ), MODERN DENTAL (HKEx), ANGIODYNAMICS INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), SINGULAR GENOMICS SYSTEMS INC (NASDAQ), CRYOLIFE INC (NYSE), CIRC (HKEx), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), EARGO INC (NASDAQ), CUTERA INC (NASDAQ), SISRAM MED (HKEx), SURMODICS INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), SI BONE INC (NASDAQ), BIOVENTUS INC (NASDAQ), NYXOAH SA (NASDAQ), CHUNLI MEDICAL (HKEx), INTERCURE LTD (NASDAQ), VAPOTHERM INC (NYSE), KDL MEDICAL (HKEx), PAVMED INC (NASDAQ), AXOGEN INC (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), ACOTEC-B (HKEx), INFUSYSTEM HOLDINGS INC (NYSE American), SEASPINE HOLDINGS CORP (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), HEARTCARE-B (HKEx), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), AVITA MEDICAL INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), SOLITON INC (NASDAQ), METRICS INCOME OPPORTUNITIES TRUST (ASX), CLEARPOINT NEURO INC (NASDAQ), ZYNEX INC (NASDAQ), BASECARE-B (HKEx), STEREOTAXIS INC (NYSE American), MISONIX INC (NASDAQ), NEUROPACE INC (NASDAQ), IRADIMED CORP (NASDAQ), TALIS BIOMEDICAL CORP (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), CYTOSORBENTS CORP (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), ACCELERATE DIAGNOSTICS INC (NASDAQ), ONCOCYTE CORP (NASDAQ), ACUTUS MEDICAL INC (NASDAQ), SIENTRA INC (NASDAQ), CONFORMIS INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), INCANNEX HEALTHCARE LTD (ASX), YESTAR HEALTH (HKEx), CVRX INC (NASDAQ), LUCIRA HEALTH INC (NASDAQ), PROFOUND MED CORP (NASDAQ), ICECURE MEDICAL LTD (NASDAQ), QUOTIENT LTD (NASDAQ), MYMD PHARMACEUTICALS INC (NASDAQ), AROA BIOSURGERY LTD (ASX), APOLLO ENDOSURGERY INC (NASDAQ), CLARITY PHARMACEUTICALS LTD (ASX), PW MEDTECH (HKEx), DARIOHEALTH CORP (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), MEDICAL DEVELOPMENT INTL (ASX), ENLIVEX THERAPEUTICS LTD (NASDAQ), INVACARE CORP (NYSE), TELA BIO INC (NASDAQ), INTRICOM CORP (NASDAQ), SURGALIGN HOLDINGS INC (NASDAQ), UGHealthcare (SGX), TITAN MEDICAL INC (NASDAQ), CORMEDIX INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD (NASDAQ), Medtecs Intl (SGX), NEURONETICS INC (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), EMVISION MEDICAL DEVICES LTD (ASX), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), ATOMO DIAGNOSTICS LIMITED (ASX), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), SOMNOMED LIMITED (ASX), REPRO MEDSYSTEMS INC (NASDAQ), VENUS CONCEPT INC (NASDAQ), CYCLOPHARM LIMITED (ASX), IMPEDIMED LIMITED (ASX), ALPHA PRO TECH (NYSE American), LUMOS DIAGNOSTICS HOLDINGS LIMITED (ASX), FONAR CORP (NASDAQ), IRIDEX CORP (NASDAQ), MEDAVAIL HOLDINGS INC (NASDAQ), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), KELFRED (HKEx), ELECTROMED INC (NYSE American), OPTISCAN IMAGING (ASX), BIOLASE INC (NASDAQ), CRYO-CELL INTERNATIONAL INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), MICRO-X LTD (ASX), CHECK-CAP LTD (NASDAQ), NEPHROS INC (NASDAQ), CELSION CORPORATION (NASDAQ), SDI LTD (ASX), VINCENT MED (HKEx), HANCOCK JAFFE LABORATORIES INC (NASDAQ), LENSAR INC (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), VOLITIONRX LIMITED (NYSE American), AVINGER INC (NASDAQ), CLEANSPACE HOLDINGS LTD (ASX), SOLENO THERAPEUTICS INC (NASDAQ), IMMUCELL CORP (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), ELECTROCORE INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), PREDICTIVE ONCOLOGY INC (NASDAQ), APPLIED UV INC (NASDAQ), NEUROMETRIX INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), BIOMERICA INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), COMPUMEDICS (ASX), YUNNAN ENERGY (HKEx), AETHLON MEDICAL INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), IMAGION BIOSYSTEMS LIMITED (ASX), NEOVASC INC (NASDAQ), DIMERIX LTD (ASX), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), RESHAPE LIFESCIENCES INC (NASDAQ), DAXOR CORP (NYSE American), NOVA EYE MEDICAL LIMITED (ASX), CARDIEX LTD (ASX), RESPIRI LTD (ASX), BELLEROPHON THERAPEUTICS INC (NASDAQ), KEWAUNEE SCIENTIFIC CORP (NASDAQ), INSPIREMD INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), Yunnan Energy (SGX), TENAX THERAPEUTICS INC (NASDAQ), RESONANCE HEALTH LTD (ASX), SINTX TECHNOLOGIES INC (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), LBT INNOVATIONS LTD (ASX), PLUS THERAPEUTICS INC (NASDAQ), PETVIVO HLDGS INC (NASDAQ), NUWELLIS INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), ADHERIUM LIMITED (ASX), Biolidics (SGX), VIVEVE MEDICAL INC (NASDAQ), INSPIRA TECH OXY BHN LTD (NASDAQ), DYNATRONICS CORP (NASDAQ), NEUROTECH INTERNATIONAL LTD (ASX), RA MEDICAL SYSTEMS INC (NYSE American), XTANT MEDICAL HLDGS INC (NYSE American), OVENTUS MEDICAL LTD (ASX), ALLEGRA ORTHOPAEDICS LIMITED (ASX), LIFE HEALTHCARE (HKEx), CYANOTECH CORP (NASDAQ), METALICITY LIMITED (ASX), OSPREY MEDICAL INC NPV DFD 23/09/21(EX-SPLIT) (ASX), USCOM LTD (ASX), TRUSCREEN GROUP LTD (ASX), STAR EQUITY HOLDINGS INC (NASDAQ), Annica (SGX), HUAKANG BIOMED (HKEx), ANALYTICA (ASX), STHAI (SET)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.370
-10.79 %
10 Days --0.680
-18.18 %
20 Days --0.740
-19.47 %
Medium Term Return 3 Months 0.180-1.586
-30.26 %
6 Months 0.432-2.288
-34.70 %
1 Year 0.682-4.829
-52.57 %
Long Term Return 2 Years 0.822+1.495
+148.05 %
3 Years 0.907+1.297
+125.01 %
5 Years 1.207+2.267
+438.08 %
Annualised Return Annualised --
+40.01 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 2.950 - 9.609 Change From 1 Year Low +0.110 % Change From 1 Year Low (%) +3.73
Change From 1 Year High -6.549 % Change From 1 Year High (%) -68.16
2 Years Range 1.387 - 9.655 Change From 2 Years Low +1.673 % Change From 2 Years Low (%) +120.57
Change From 2 Years High -6.595 % Change From 2 Years High (%) -68.31
5 Years Range 0.751 - 9.655 Change From 5 Years Low +2.309 % Change From 5 Years Low (%) +307.29
Change From 5 Years High -6.595 % Change From 5 Years High (%) -68.31
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Established in 1991 with only one factory and three production lines, Top Glove has since grown by leaps and bounds to become the world's largest rubber glove manufacturer. It was listed on the Malaysian bourse, Bursa Saham Kuala Lumpur on 27 March 2001. In a short span of slightly more than a year, on 16 May 2002, Top Glove Corporation Berhad's listing was successfully promoted from the Second Board to the Main Market of the Kuala Lumpur Stock Exchange. Top Glove has a shareholder fund of RM1.09 billion or USD358 million with an annual turnover of about RM2.08 billion or USD682 million as at financial year ended 31 August 2010. It is also one of the component stocks of the FTSE Bursa Malaysia ("FBM") Mid 70 Index, FBM Top 100 Index and FBM Emas Index with a market capitalization of RM3.28 billion as at 30 March 2011.

IPO Performance

Listing Date 27 Mar 2001 Full Subscription Rate (x) -
No of Placement Shares (M) - No of Public Offer Shares (M) 7.51 Public Offer Subscription Rate (x) -
IPO Price (MYR) 2.700 First Day Close (MYR) 0.495 First Week Close (MYR) 0.398
Current vs IPO Price (%) +13.33 First Day Gain (%) -81.67 First Week Gain (%) -85.26

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2019 Aug 2019 Part 1(2.73 MB)
Part 2(2.39 MB)
Part 3(2.33 MB)
Part 4(2.51 MB)
Annual Report 2018 Aug 2018 Part 1(2.52 MB)
Part 2(1.90 MB)
Part 3(0.17 MB)
Part 4(0.62 MB)
Annual Report 2017 Aug 2017 Part 1(0.59 MB)
Part 2(3.00 MB)
Part 3(1.65 MB)
Annual Report 2016 Aug 2016 Part 1(2.73 MB)
Part 2(2.70 MB)
Part 3(2.62 MB)
Annual Report 2015 Aug 2015 Part 1(2.78 MB)
Part 2(0.83 MB)
Annual Report 2014 Aug 2014 Part 1(2.59 MB)
Part 2(1.36 MB)
Annual Report 2013 Aug 2013 Part 1(2.76 MB)
Part 2(1.78 MB)
Annual Report 2012 Aug 2012 Part 1(2.78 MB)
Annual Report 2011 Aug 2011 Part 1(2.86 MB)
Annual Report 2010 Aug 2010 Part 1(2.97 MB)
Part 2(3.08 MB)
Annual Report 2009 Aug 2009 Part 1(1.95 MB)
Part 2(2.87 MB)
Annual Report 2008 Aug 2008 Part 1(3.46 MB)
Annual Report 2007 Aug 2007 Part 1(2.84 MB)
Part 2(1.69 MB)
Annual Report 2006 Aug 2006 Part 1(1.89 MB)
Annual Report 2005 Aug 2005 Part 1(0.49 MB)
Part 2(0.18 MB)
Part 3(1.92 MB)
Part 4(1.57 MB)
Part 5(0.65 MB)
Part 6(0.26 MB)
Part 7(0.32 MB)
Part 8(1.36 MB)
Part 9(1.38 MB)
Part 10(1.01 MB)
Annual Report 2004 Aug 2004 Part 1(1.35 MB)
Part 2(0.80 MB)
Part 3(0.50 MB)
Part 4(2.43 MB)
Part 5(1.35 MB)
Part 6(0.95 MB)
Part 7(1.41 MB)
Annual Report 2003 Aug 2003 Part 1(0.54 MB)
Part 2(0.50 MB)
Part 3(3.55 MB)
Part 4(0.53 MB)
Part 5(0.78 MB)
Part 6(0.86 MB)
Annual Report 2002 Aug 2002 Part 1(0.69 MB)
Part 2(0.51 MB)
Part 3(0.76 MB)
Part 4(0.41 MB)
Annual Report 2001 Aug 2001 Part 1(0.93 MB)
Part 2(0.31 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
17 Sep 2021 3.230 3.320 2.950 3.060 63,601,100 3.1103
15 Sep 2021 3.230 3.250 3.120 3.200 35,229,500 3.1595
14 Sep 2021 3.280 3.330 3.160 3.230 36,810,500 3.2144
13 Sep 2021 3.450 3.470 3.260 3.280 31,603,200 3.3243
10 Sep 2021 3.700 3.750 3.400 3.430 71,185,700 3.5275
09 Sep 2021 3.580 3.590 3.380 3.400 37,846,900 3.4368
08 Sep 2021 3.670 3.670 3.540 3.580 37,305,300 3.5865
07 Sep 2021 3.720 3.750 3.670 3.670 19,030,600 3.6894
06 Sep 2021 3.770 3.770 3.710 3.720 7,869,100 3.7249
03 Sep 2021 3.860 3.880 3.720 3.740 21,000,300 3.7547
02 Sep 2021 3.930 3.950 3.850 3.860 8,332,500 3.8839
01 Sep 2021 3.980 4.000 3.920 3.920 14,464,500 3.9556
30 Aug 2021 3.900 4.000 3.870 4.000 18,801,200 3.9503
27 Aug 2021 3.860 3.970 3.840 3.910 13,152,400 3.9064
26 Aug 2021 3.910 3.950 3.840 3.860 11,729,500 3.8807
25 Aug 2021 3.850 3.980 3.820 3.920 12,468,200 3.9095
24 Aug 2021 3.770 3.850 3.740 3.850 7,651,600 3.8078
23 Aug 2021 3.800 3.800 3.750 3.760 3,415,600 3.7680
20 Aug 2021 3.800 3.820 3.770 3.800 3,361,900 3.7864
19 Aug 2021 3.900 3.910 3.770 3.770 10,427,500 3.8090
18 Aug 2021 3.800 3.950 3.750 3.930 14,732,000 3.8721
17 Aug 2021 3.700 3.800 3.700 3.770 7,574,900 3.7631
Summary
Current 2 Weeks
(03 Sep 2021 to 17 Sep 2021)
3.860 3.880 2.950 3.060 361,482,200 -
Previous 2 Weeks
(19 Aug 2021 to 02 Sep 2021)
3.900 3.910 2.950 3.860 103,804,900 -
4 Weeks from
(21 Jul 2021 to 18 Aug 2021)
3.990 4.180 2.950 3.930 323,120,700 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.